Company Expects to Complete Ongoing Multi-Center Phase II Imaging Trial of I-124-CLR1404 in Patients with Glioblastoma By Year-End May 5, 2014 Cellectar Biosciences, Inc., a …
Company Expects to Complete Ongoing Multi-Center Phase II Imaging Trial of I-124-CLR1404 in Patients with Glioblastoma By Year-End May 5, 2014 Cellectar Biosciences, Inc., a …